FDA Guidance
Official FDA guidance documents for medical devices and radiation-emitting products
106 resourcesPolicy for Device Software Functions and Mobile Medical Applications
Final FDA guidance on software & digital health. Published 2022 by CDRH/CBER.
View DocumentRecommendations for the Use of Clinical Data in Premarket Notification 510(k) Submissions
Draft FDA guidance on clinical evidence. Published 2023 by CDRH/CBER.
View DocumentEvidentiary Expectations for 510(k) Implant Devices
Draft FDA guidance on 510(k). Published 2023 by CDRH/CBER.
View DocumentBest Practices for Selecting a Predicate Device to Support a 510(k) Submission
Draft FDA guidance on 510(k). Published 2023 by CDRH/CBER.
View DocumentBreakthrough Devices Program
Final FDA guidance on breakthrough devices. Published 2023 by CDRH/CBER.
View DocumentUse of International Standard ISO 10993-1: Biological Evaluation of Medical Devices
Final FDA guidance on biocompatibility. Published 2023 by CDRH/CBER.
View DocumentSubmission and Review of Sterility Information in Premarket Notification 510(k) Submissions for Devices Labeled as Sterile
Final FDA guidance on 510(k). Published 2024 by CDRH/CBER.
View DocumentProcess to Request a Review of FDA’s Decision Not to Issue Certain Export Certificates for Devices
Final FDA guidance on export & international. Published 2023 by CDRH/CBER.
View DocumentElectronic Submission Template for Medical Device 510(k) Submissions
Final FDA guidance on 510(k). Published 2023 by CDRH/CBER.
View DocumentFDA and Industry Procedures for Section 513(g) Requests for Information
Final FDA guidance on classification. Published 2024 by CDRH/CBER.
View DocumentPredetermined Change Control Plans for Medical Devices
Draft FDA guidance on change management. Published 2024 by CDRH/CBER.
View DocumentRemanufacturing of Medical Devices
Final FDA guidance on manufacturing. Published 2024 by CDRH/CBER.
View DocumentVoluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers
Final FDA guidance on post-market surveillance. Published 2024 by CDRH/CBER.
View DocumentElectronic Submission Template for Medical Device De Novo Requests
Final FDA guidance on de novo. Published 2024 by CDRH/CBER.
View DocumentBiocompatibility Testing of Medical Devices — ASCA Program
Draft FDA guidance on biocompatibility. Published 2024 by CDRH/CBER.
View DocumentThe Accreditation Scheme for Conformity Assessment (ASCA) Program
Draft FDA guidance on standards & conformity. Published 2024 by CDRH/CBER.
View DocumentChemical Analysis for Biocompatibility Assessment of Medical Devices
Draft FDA guidance on biocompatibility. Published 2024 by CDRH/CBER.
View DocumentIncorporating Voluntary Patient Preference Information over the Total Product Life Cycle
Draft FDA guidance on patient engagement. Published 2024 by CDRH/CBER.
View DocumentBasic Safety and Essential Performance of Medical Electrical Equipment — ASCA Program
Draft FDA guidance on standards & conformity. Published 2024 by CDRH/CBER.
View DocumentGlobal Unique Device Identification Database (GUDID)
Final FDA guidance on udi. Published 2024 by CDRH/CBER.
View DocumentPremarket Approval Application and Humanitarian Device Exemption Modular Review
Final FDA guidance on pma. Published 2025 by CDRH/CBER.
View DocumentNotifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J
Final FDA guidance on manufacturing. Published 2025 by CDRH/CBER.
View DocumentArtificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations
Final FDA guidance on ai/ml & software. Published 2025 by CDRH/CBER.
View DocumentElectronic Submission Template for Medical Device Q-Submissions
Draft FDA guidance on submission process. Published 2025 by CDRH/CBER.
View Document